PL1786401T3 - Kompozycja o szybkim uwalnianiu zawierająca stopione granulki leku wrażliwego na wilgoć i sposób ich wytwarzania - Google Patents

Kompozycja o szybkim uwalnianiu zawierająca stopione granulki leku wrażliwego na wilgoć i sposób ich wytwarzania

Info

Publication number
PL1786401T3
PL1786401T3 PL05775067T PL05775067T PL1786401T3 PL 1786401 T3 PL1786401 T3 PL 1786401T3 PL 05775067 T PL05775067 T PL 05775067T PL 05775067 T PL05775067 T PL 05775067T PL 1786401 T3 PL1786401 T3 PL 1786401T3
Authority
PL
Poland
Prior art keywords
manufacturing
composition including
release composition
moisture sensitive
fast release
Prior art date
Application number
PL05775067T
Other languages
English (en)
Inventor
James Kowalski
Oskar Kalb
Abu T M Serajuddin
Yatindra Joshi
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35447883&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1786401(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL1786401T3 publication Critical patent/PL1786401T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL05775067T 2004-08-27 2005-08-26 Kompozycja o szybkim uwalnianiu zawierająca stopione granulki leku wrażliwego na wilgoć i sposób ich wytwarzania PL1786401T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60532704P 2004-08-27 2004-08-27
US61682804P 2004-10-07 2004-10-07
EP05775067.1A EP1786401B1 (en) 2004-08-27 2005-08-26 Fast release composition including melt granules of a moisture sensitive drug and process for manufacturing thereof
PCT/EP2005/009252 WO2006021455A1 (en) 2004-08-27 2005-08-26 Fast release composition including melt granules of a moisture sensitive drug and process for manufacturing thereof

Publications (1)

Publication Number Publication Date
PL1786401T3 true PL1786401T3 (pl) 2018-01-31

Family

ID=35447883

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05775067T PL1786401T3 (pl) 2004-08-27 2005-08-26 Kompozycja o szybkim uwalnianiu zawierająca stopione granulki leku wrażliwego na wilgoć i sposób ich wytwarzania

Country Status (21)

Country Link
US (1) US20080050443A1 (pl)
EP (2) EP3087975A1 (pl)
JP (1) JP5147399B2 (pl)
KR (8) KR101613775B1 (pl)
CN (1) CN101010068B (pl)
AR (1) AR050615A1 (pl)
AU (1) AU2005276583B2 (pl)
BR (1) BRPI0514682B8 (pl)
CA (1) CA2575499A1 (pl)
DK (1) DK1786401T3 (pl)
ES (1) ES2647671T3 (pl)
HU (1) HUE034653T2 (pl)
MX (1) MX2007002253A (pl)
MY (1) MY144297A (pl)
PE (1) PE20060652A1 (pl)
PL (1) PL1786401T3 (pl)
PT (1) PT1786401T (pl)
RU (1) RU2383332C2 (pl)
SI (1) SI1786401T1 (pl)
TW (1) TWI402082B (pl)
WO (1) WO2006021455A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2684325T5 (es) 2004-01-20 2024-06-10 Novartis Ag Formulación y proceso de compresión directa
CA2554493C (en) 2004-02-05 2012-06-26 Kyorin Pharmaceutical Co., Ltd. Bicycloester derivative
PE20060652A1 (es) 2004-08-27 2006-08-11 Novartis Ag Composiciones farmaceuticas de liberacion inmediata que comprenden granulos de fusion
JP5101489B2 (ja) 2006-03-08 2012-12-19 杏林製薬株式会社 アミノアセチルピロリジンカルボニトリル誘導体の製造方法およびその製造中間体
WO2007128801A1 (en) * 2006-05-08 2007-11-15 Novartis Ag Combination of organic compounds
ATE550319T1 (de) 2007-03-22 2012-04-15 Kyorin Seiyaku Kk Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats
DE102008020701A1 (de) * 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulierung mit reduzierter Hygroskopizität
CA2732984A1 (en) 2008-08-07 2010-02-11 Kyorin Pharmaceutical Co., Ltd. Process for production of bicyclo[2.2.2]octylamine derivative
KR20110044780A (ko) * 2008-08-14 2011-04-29 교린 세이야꾸 가부시키 가이샤 안정화된 의약 조성물
AR073651A1 (es) * 2008-09-24 2010-11-24 Novartis Ag Formulaciones galenicas de compuestos organicos
CN102438617A (zh) 2009-03-27 2012-05-02 杏林制药株式会社 含有碱性添加剂的基质型缓释制剂
JP2011057586A (ja) * 2009-09-08 2011-03-24 Kyorin Pharmaceutical Co Ltd ｐＨ非依存性マトリックス型徐放性製剤
TR201002256A1 (tr) * 2010-03-24 2011-10-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Stabil aliskiren formülasyonları
US8989577B2 (en) 2012-06-21 2015-03-24 Qualcomm Incorporated Methods and systems for implementing time-division duplexing in the physical layer
US9071358B2 (en) 2012-06-21 2015-06-30 Qualcomm Incrorporated Repeater fiber-coax units
US9363017B2 (en) 2012-07-06 2016-06-07 Qualcomm Incorporated Methods and systems of specifying coaxial resource allocation across a MAC/PHY interface
JP6283316B2 (ja) * 2012-10-26 2018-02-21 株式会社三和化学研究所 アナグリプチン含有固形製剤
US10369108B2 (en) * 2013-03-15 2019-08-06 Mylan Laboratories, Inc. Hot melt granulation formulations of poorly water-soluble active agents
CN104274408A (zh) * 2013-07-10 2015-01-14 北京科信必成医药科技发展有限公司 一种熔融包衣的速释药物微粒及其制备方法
WO2015195990A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Liquid-filled immediate release soft gelatin capsules
ES2946233T3 (es) 2016-09-16 2023-07-14 Galenicum Health S L U Composiciones farmacéuticas de vildagliptina

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
DK0654263T3 (da) 1993-11-23 2002-04-29 Euro Celtique Sa Fremgangsmåde til fremstilling af et præparat med langvarig frigivelse
IL111785A0 (en) 1993-12-03 1995-01-24 Ferring Bv Dp-iv inhibitors and pharmaceutical compositions containing them
US20020142037A1 (en) * 1996-10-01 2002-10-03 Nabil Farah Process for the manufacture of a pharmaceutical composition with modified release of active principle comprising a matrix
AU4721897A (en) 1996-10-25 1998-05-22 Tanabe Seiyaku Co., Ltd. Tetrahydroisoquinoline derivatives
TW492957B (en) 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US6011155A (en) 1996-11-07 2000-01-04 Novartis Ag N-(substituted glycyl)-2-cyanopyrrolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
JP2002522354A (ja) * 1997-09-19 2002-07-23 シャイア ラボラトリーズ，インコーポレイテッド 固溶体ビードレット
DE19823831A1 (de) 1998-05-28 1999-12-02 Probiodrug Ges Fuer Arzneim Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen
CO5150173A1 (es) 1998-12-10 2002-04-29 Novartis Ag Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
US6107317A (en) 1999-06-24 2000-08-22 Novartis Ag N-(substituted glycyl)-thiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
MXPA03006918A (es) 2001-02-02 2004-05-24 Takeda Chemical Industries Ltd Compuestos heterociclicos fusionados.
UA74912C2 (en) 2001-07-06 2006-02-15 Merck & Co Inc Beta-aminotetrahydroimidazo-(1,2-a)-pyrazines and tetratriazolo-(4,3-a)-pyrazines as inhibitors of dipeptylpeptidase for the treatment or prevention of diabetes
US7985422B2 (en) * 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
EP1537880A4 (en) * 2002-09-11 2009-07-01 Takeda Pharmaceutical PREPARATION FOR PROLONGED RELEASE
WO2004037169A2 (en) 2002-10-18 2004-05-06 Merck & Co., Inc. Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
EP1553937B1 (en) 2002-10-23 2010-06-02 Bristol-Myers Squibb Company Glycinenitrile-based inhibitors of dipeptidyl peptidase iv
PE20060652A1 (es) 2004-08-27 2006-08-11 Novartis Ag Composiciones farmaceuticas de liberacion inmediata que comprenden granulos de fusion

Also Published As

Publication number Publication date
HUE034653T2 (hu) 2018-02-28
EP3087975A1 (en) 2016-11-02
AU2005276583A1 (en) 2006-03-02
KR20190006612A (ko) 2019-01-18
KR20160136465A (ko) 2016-11-29
KR20160017123A (ko) 2016-02-15
CA2575499A1 (en) 2006-03-02
MX2007002253A (es) 2007-04-20
KR20130043697A (ko) 2013-04-30
JP2008510764A (ja) 2008-04-10
AR050615A1 (es) 2006-11-08
EP1786401A1 (en) 2007-05-23
KR20200087870A (ko) 2020-07-21
EP1786401B1 (en) 2017-08-16
ES2647671T3 (es) 2017-12-26
AU2005276583B2 (en) 2009-12-03
RU2007110953A (ru) 2008-10-10
TW200613005A (en) 2006-05-01
MY144297A (en) 2011-08-29
US20080050443A1 (en) 2008-02-28
KR101613775B1 (ko) 2016-04-19
RU2383332C2 (ru) 2010-03-10
CN101010068B (zh) 2013-05-22
TWI402082B (zh) 2013-07-21
BRPI0514682A (pt) 2008-06-17
KR20070049646A (ko) 2007-05-11
CN101010068A (zh) 2007-08-01
KR20170103039A (ko) 2017-09-12
PT1786401T (pt) 2017-11-22
BRPI0514682B1 (pt) 2019-06-04
DK1786401T3 (da) 2017-11-27
WO2006021455A1 (en) 2006-03-02
SI1786401T1 (sl) 2017-12-29
KR20220061249A (ko) 2022-05-12
BRPI0514682B8 (pt) 2021-05-25
PE20060652A1 (es) 2006-08-11
JP5147399B2 (ja) 2013-02-20

Similar Documents

Publication Publication Date Title
SI1786401T1 (sl) Sestavek s hitrim sproščanjem, ki vključuje s talino dobljene granule zdravila, občutljivega za vlago, in postopek za izdelavo le-teh
EP1620075A4 (en) HIGH PELLETS OF PLASTIC, FOR THE MANUFACTURE OF RAPID DISSOLUTION COMPRESSES
GB2456989B (en) Granules, tablets and granulation
ZA200711059B (en) Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
PL1906775T3 (pl) Urządzenie do palenia zawierające łamliwą kapsułkę, łamliwa kapsułka i sposób wytwarzania wymienionej kapsułki
GB2402063B (en) Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof
HK1078006A1 (en) Immediate release pharmaceutical granule compositions and a continuous process for making them
EP2084519A4 (en) ADVANCED PRODUCTION AND MANUFACTURE OF MEDICINES
TWI368523B (en) Pharmaceutical compositions comprising imatinib and a release retardant
EP1852109A4 (en) XYLITOL PELLETS THAT CAN BE TRANSFORMED DIRECTLY IN TABLETS AND PROCESS FOR THE PREPARATION THEREOF
PL1650517T3 (pl) Osuszacz adsorpcyjny do granulek z tworzyw sztucznych
HK1090603A1 (en) Mold release composition and process therewith
EP1853110A4 (en) PROCESS FOR THE PRODUCTION OF AN EASILY AVAILABLE CELLULAR SUBSTANCE DERIVED FROM PERIPHERAL BLOOD AND COMPOSITION THEREOF
IL188177A0 (en) Novel granulation process and granulate produced therefrom
PL1604690T3 (pl) Kompozycje polimerowe kleju termotopliwego do przedłużonego uwalniania substancji lotnych
EP1802346A4 (en) PHARMACEUTICAL COMPOSITION WITH EXTENDED RELEASE
EP2035410A4 (en) PROCESS FOR PREPARING ESOMEPRAZOLE AND ITS SALTS
EP1976490A4 (en) EXTENDED RELEASE TABLET CONTAINING ZALTOPROFEN AND PROCESS FOR PREPARING SAID TABLET
EP2030612A4 (en) PHARMACEUTICAL COMPOSITION FOR TREATING COMBUSTIONS (VARIATIONS) AND METHOD FOR THE PRODUCTION THEREOF (VARIANTS)
SI1909761T1 (sl) Farmacevtski sestavek, ki obsega granuliran pantoprazol
HUP0401170A2 (en) Pharmaceutical composition comprising amlodipine besilate and lisinopril dihydrate and process for
EP1806151A4 (en) MEDICAMENT FOR EXTERNAL APPLICATION AND SELF-ADHESIVE ASSOCIATION
EP1897898A4 (en) DEGRADABLE POLYMER AND PROCESS FOR PRODUCING THE POLYMER
PT1864677E (pt) Formulação estável compreendendo um fármaco sensível à humidade e processo para a sua produção
IL195060A0 (en) Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof